ATC Group: G03AA13 Norelgestromin and ethinylestradiol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G03AA13 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G03 Sex hormones and modulators of the genital system
3 G03A Hormonal contraceptives for systemic use
4 G03AA Progestogens and estrogens, fixed combinations
5 G03AA13 Norelgestromin and ethinylestradiol

Related product monographs

Title Information Source Document Type  
EVRA Plaster European Medicines Agency (EU) MPI, EU: SmPC
XULANE Patch FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Austria (AT)

  • (combination) EVRA

Brazil (BR)

  • (combination) EVRA

Canada (CA)

  • (combination) EVRA

Croatia (HR)

  • (combination) EVRA

Ecuador (EC)

  • (combination) EVRA

Estonia (EE)

  • (combination) EVRA

Finland (FI)

  • (combination) EVRA

France (FR)

  • (combination) EVRA

Ireland (IE)

  • (combination) EVRA

Israel (IL)

  • (combination) EVRA

Italy (IT)

  • (combination) EVRA

Lithuania (LT)

  • (combination) EVRA

Mexico (MX)

  • (combination) EVRA

Netherlands (NL)

  • (combination) EVRA

Poland (PL)

  • (combination) EVRA

Romania (RO)

  • (combination) EVRA

Singapore (SG)

  • (combination) EVRA

South Africa (ZA)

  • (combination) EVRA

Spain (ES)

  • (combination) EVRA

United Kingdom (UK)

  • (combination) EVRA

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.